Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
Cancer. 1998 May 1;82(9):1664-71. doi: 10.1002/(sici)1097-0142(19980501)82:9<1664::aid-cncr11>3.0.co;2-2.
Cancer. 1998.
PMID: 9576286
Clinical Trial.